Arcus Biosciences, Inc. (RCUS)
23.87
+0.13
(+0.55%)
USD |
NYSE |
May 21, 16:00
23.92
+0.04
(+0.19%)
Pre-Market: 19:59
Arcus Biosciences Research and Development Expense (TTM) : 523.00M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.703B |
| ACADIA Pharmaceuticals, Inc. | 327.40M |
| Alnylam Pharmaceuticals, Inc. | 1.420B |
| Amgen, Inc. | 7.514B |
| Catalyst Pharmaceuticals, Inc. | 11.48M |